Dual Targeting of PD-1/PD-L1 and Il-33/ST2 Signaling Pathways: A Promising Approach in Breast Cancer Immunotherapy

Investigators sysnthesize current literature on the PD-1/PD-L1 and IL-33/ST2 pathways in breast cancer progression, focusing on their mechanisms of immune suppression and tumor microenvironment modulation.